Advanced Biotechnologies, Inc.

Advanced Biotechnologies Inc is excited to announce its attendance at the American Molecular Pathology (AMP) Annual Meeting in Phoenix, Arizona from November 14–16.

Columbia, Maryland – August 8, 2013 – Advanced Biotechnologies Inc (ABI), a leading biotech manufacturer of rare viral reagents, has named Randall Whitman as President.

Columbia, MD – June 26, 2013 – Advanced Biotechnologies Inc (ABI) has released EBV (B95-8 Strain) Quantitated Viral Load Control (Catalog No. T9-107-175) and HSV-1 (MacIntyre Strain) Quantitated Viral Load Control (Catalog No. T9-108-175).

Advanced Biotechnologies Inc Releases New Quantitated Viral Load Controls Columbia, MD – August 14, 2012 – Advanced Biotechnologies Inc (ABI) has released HCMV (AD169 Strain) Quantitated Viral Load Control (Catalog No.

Advanced Biotechnologies Inc Releases HIV-1 (IIIB Strain) Purified Viral Lysate Columbia, Maryland – March 11, 2013 – Advanced Biotechnologies Inc (ABI) has released HIV-1 (IIIB Strain) Purified Viral Lysate (Catalog No. 10-121-000).

Advanced Biotechnologies (ABI) has launched its brand new company website.

Columbia, Maryland - October 1, 2012 - Advanced Biotechnologies Inc (ABI) has released Adult Human Elutriated Lymphocytes (Catalog No. 07-212-001).

Columbia, Maryland – July 23, 2012 – Advanced Biotechnologies Inc, a leading international biotech manufacturer specializing in premium viral reagents and biological research services, has added a new hire to its IT staff.